Successful treatment of pediatric post-liver transplant Kaposi`s sarcoma with paclitaxel.
BACKGROUND
Kaposi`s sarcoma (KS) is a complication of immunosuppressive therapy for transplant recipients. Unlike adult recipients, KS in pediatric organ transplantation is quite rare. Treatment is usually withdrawal of immunosuppression; non-responders often receive chemotherapy.


CASE
We have reported a child with post-liver transplant visceral KS which has progressed despite withdrawal of immunosuppressive therapy, who has been treated with Paclitaxel for three weeks. KS has regressed completely after four cycles of Paclitaxel.


CONCLUSION
Paclitaxel should be considered as an effective first line treatment option for patients with posttransplant KS.
['Şen|Hilal Susam|HS|', 'Ateş|Belen Terlemez|BT|', 'Yılmazbaş|Pınar|P|', 'Ocak|Süheyla|S|', 'Kırımlıoğlu|Hale|H|', 'Gökçe|Selim|S|', 'Acarlı|Koray|K|']
D000328:Adult D002648:Child D006801:Humans D007165:Immunosuppression Therapy D016031:Liver Transplantation D017239:Paclitaxel D012514:Sarcoma, Kaposi D066027:Transplant Recipients
Kaposi`s sarcoma paclitaxel children